Positive Results for Viromed VAP Therapy
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Read MoreUsing machine learning, researchers identified five clinical states in pneumonia patients, with three associated with specific disease outcomes and two that may help pinpoint the disease’s cause.
Read MorePneumonia is a potentially life-threatening infection of the lungs that inflames alveoli and spurs the overproduction of purulent material. Typically afflicting neonates and seniors, the COVID pandemic has revealed the importance of proper pneumonia care for all patients.
Read MoreMany children with recurrent wheezing have undetected lung infections that may be more effectively treated with antivirals instead of commonly prescribed steroids.
Read MoreExposure to other viruses and bacteria may have enhanced children’s immune responses, helping them avoid severe COVID-19 symptoms.
Read MoreUH15-38 shows potential in preventing lung injury and reducing inflammation in severe influenza when administered even five days after infection.
Read MorebioMérieux received FDA 510(k) clearance and CLIA waiver approval for the Biofire Spotfire Respiratory/Sore Throat (R/ST) Panel.
Read MoreThe composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections.
Read MoreChinese scientists are testing an experimental intranasal mask to protect the respiratory tract against viral aerosols.
Read MoreSome childhood exposures, such as parental smoking and respiratory tract infections, are risk factors for obstructive sleep apnea in middle-aged adults, researchers find.
Read MoreResearchers demonstrated in mice that molecules in certain vegetables help to maintain a healthy barrier in the lungs and ease infection during illness.
Read MoreTwo new studies explain why babies get so many common respiratory infections and identify a specialized cluster of immune cells found only in babies that help them better cope with new pathogens.
Read MoreInvestigators determined which types of neighborhoods are associated with a greater incidence rate of hospitalization due to COVID-19.
Read MoreThe clearance allows FebriDx to be marketed in the United States for use by healthcare professionals as an aid in the diagnosis of bacterial acute respiratory infection and differentiation from non-bacterial etiology in patients presenting in urgent care or emergency care settings.
Read MoreNew research to be presented at the European Congress of Clinical Microbiology & Infectious Diseases suggests restrictive antibiotic strategy for viral respiratory infections like influenza may be warranted.
Read MoreContracting a lower respiratory tract infection before age 2 may increase the risk of dying prematurely in adulthood from a respiratory disease.
Read MoreResearchers say the discovery is essential to developing future therapies to limit viral infection and improve the health of patients with chronic lung disease.
Read MoreResearchers have discovered a compound that inhibits the body’s own methyltransferase MTr1, which limits the replication of influenza viruses and may lead to the development of new treatments for the flu.
Read MoreUBC researchers have identified three compounds derived from natural sources, including a British Columbia sea sponge, that prevent COVID-19 infection in human cells.
Read MoreResearchers from the NIAID, part of the NIH, explore the challenges and outline approaches to improved mucosal vaccines.
Read MoreA “smart” face mask can detect common respiratory viruses, including influenza and the coronavirus, in the air and can alert the wearer via their smartphone within 10 minutes if targeted pathogens are detected.
Read MoreIn patients with cystic fibrosis listed for lung transplantation, a frailty index based on standard multidisciplinary lung transplant assessment data facilitates patient risk stratification.
Read MoreA review in Small Structures summarizes the recent advances in nanomaterial-based antiviral strategies, mainly including antiviral nano-drugs, drug nanocarriers, and nano-vaccines.
Read MoreRespiratory virus infections are the main trigger for asthma exacerbations in children, according to a study presented recently at the American Academy of Allergy, Asthma & Immunology Annual Meeting in Phoenix.
Read More